ESCAPE-MeVO trial advances understanding of stroke treatment for medium-sized vessel blockages

University of Calgary’s Hotchkiss Brain Institute researchers with the Calgary Stroke Program at Foothills Medical Centre revolutionized treatment for stroke with the ESCAPE Trial, proving that a clot retrieval procedure known as endovascular thrombectomy (EVT) can dramatically improve patient outcomes after an acute ischemic stroke caused by a blockage in a large-sized blood vessel.

Recombinant shingles vaccine linked to lower dementia risk, especially in women

Study published in Nature Medicine found that the recombinant shingles vaccine is linked to a reduced risk of dementia. This protective effect was particularly notable

August 8, 2024

FDA approves Roche’s second CD20xCD3 bispecific in certain lymphomas

The FDA granted accelerated approval to Genentech’s CD20xCD3 bispecific for patients with a certain type of non-Hodgkin’s lymphoma on Thursday night, as the Roche unit

June 17, 2023

Long underappreciated, gamma-delta T cells may be key to colon cancer defense, study says

Within the linings of our guts, immune cells patrol like sentries on a castle wall. These cells, called intraepithelial T lymphocytes, are constantly probing the

October 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.